Document:

Amendment to 2012 Coventry Health Care, Inc. Executive Management Incentive Plan

 Exhibit 10.2 
 AMENDMENT TO 
 2012 COVENTRY HEALTH CARE, INC. 

EXECUTIVE MANAGEMENT INCENTIVE PLAN 
 This Amendment (the “Amendment”) to the 2012 Coventry Health Care, Inc. Executive Management Incentive Plan (the “Plan”) as adopted by the Compensation Committee (the
“Committee”) of the Board of Directors (the “Board”) of Coventry Health Care, Inc. (the “Company”) at a meeting held on January 26, 2012, is made as of November 14, 2012. All capitalized
terms used and not defined herein have the meaning associated with such terms in the Plan. 
 WHEREAS, the Company’s
shareholders have previously adopted the Coventry Health Care, Inc. Amended and Restated 2004 Incentive Plan (the “Incentive Plan”); 
 WHEREAS, the Board adopted that certain Amendment to Coventry Health Care, Inc. Amended and Restated 2004 Incentive Plan Amendment (the “Incentive Plan Amendment”) as of November 14,
2012; 
 WHEREAS, the Committee adopted the Plan to provide for the grant of Performance Awards to be administered under the
Incentive Plan; 
 WHEREAS, the Plan provides for the payment of certain Incentive Awards upon the achievement of actual
Performance Measurement in excess of Performance Thresholds that were established by the Committee with respect to the Company’s performance during the Company’s 2012 fiscal year; 

WHEREAS, pursuant to Section 9.4 of the Incentive Plan, as amended, the Committee must certify in writing whether the performance
targets applicable to the relevant Performance Award have been achieved prior to the payment thereof; 
 WHEREAS, pursuant to
Section 8.2 of the Incentive Plan, the Committee has the authority to amend specific provisions of Performance Awards granted thereunder, as long as such amendments do not adversely affect existing Performance Awards; 

WHEREAS, the Committee has determined that it is in the best interests of the Company and the participants under the Plan to amend the
Plan to provide the Committee with the discretion to cause all or any portion of an Incentive Award granted pursuant to the Plan to be paid prior to the end of the performance period in the event the Committee is able to make the certification
described in Section 9.4 of the Incentive Plan prior to such payment; 
 WHEREAS, the Committee has determined that such an
amendment will not adversely affect existing Performance Awards; 
 NOW, THEREFORE, the Plan is hereby amended as follows:

 1. New Section 5(g) is hereby appended to the Plan: 

(g) Payment. The Committee may provide for the payment of all or any part of a Incentive Award at any time following the
date on which it certifies that the Performance Measurement has exceeded the applicable Performance Threshold in accordance with Section 9.4 of the Incentive Plan; provided, that all payments pursuant to the Performance Awards shall be made
prior to March 15, 2013. 

 2. This Amendment shall be effective only for Performance Awards relating to the 2012 fiscal
year of the Company. 
 3. Except as expressly modified in this Amendment, the terms and conditions of the Plan shall remain in
full force and effect.Amendment No. 2 to Warrant to Purchase Shares of Series E Preferred Stock

 Exhibit 4.2.1 
 AMENDMENT NO. 2 TO WARRANT TO PURCHASE STOCK 
 This Amendment No. 2
to Warrant to Purchase Stock (“Amendment”) is entered into as of June 20, 2012 between SVB Financial Group (“Holder”) and Ceres, Inc. (“Company”). 

Reference is made to that certain Warrant to Purchase Stock (the “Warrant”) issued by the Company in favor of Silicon Valley
Bank having the issue date of August 16, 2004, as amended on March 1, 2010, as assigned by Silicon Valley Bank to Holder. The Warrant originally granted to Holder the right to purchase 18,461 shares of the Company’s Series E Preferred
Stock at a Warrant Price of $6.50 per share. Terms defined in the Warrant are used herein as therein defined. As a result of the initial public offering of the shares of the Company’s common stock, par value $.01 per share (the “Common
Stock”), the number and/or class of securities issuable upon exercise or conversion of this Warrant has changed. 
  

			
	Pursuant to Article 2 of the Warrant, the Warrant is hereby amended as follows:
		
	Number of Shares:	  	“6153.67”
		
	Class of Stock:	  	“Common Stock”
		
	Warrant Price:	  	“$19.50 per share”

 This Amendment and the Warrant set forth in full all of the representations and agreements between the
parties with respect to the subject matter hereof and supersede all prior discussions, representations, agreements and understandings between the parties with respect to the subject hereof. Except as herein expressly amended, all of the terms and
provisions of the Warrant shall continue in full force and effect and the same are hereby ratified and confirmed. This Amendment is deemed attached to and made part of the Warrant instrument, which all together shall comprise the Warrant instrument.

  

											
	Company:	 	Holder:	 	 
			
	Ceres, Inc.	 	SVB Financial Group	 	 
						
	By:	 	 /s/ Paul Kuc
	 		 	By:	 	 /s/ Scott Newman
	 	
	Name: Paul Kuc	 	Title: Portfolio & Funding Manager	 	
	Title: Chief Financial Officer	 		 		 	

  

			
	Ceres, Inc.
		
	By:	 	 /s/ Richard Hamilton

	Name: Richard Hamilton
	Title: President & Chief Executive OfficerAmendment No. 1 to Warrant to Purchase Shares of Series F Preferred Stock

 Exhibit 4.3.1 
 AMENDMENT NO. 1 TO WARRANT TO PURCHASE STOCK 
 This Amendment No. 1
to Warrant to Purchase Stock (“Amendment”) is entered into as of June 20, 2012 between SVB Financial Group (“Holder”) and Ceres, Inc. (“Company”). 

Reference is made to that certain Warrant to Purchase Stock (the “Warrant”) issued by the Company in favor of Silicon Valley
Bank having the issue date of March 1, 2010, as assigned by Silicon Valley Bank to Holder. The Warrant originally granted to Holder the right to purchase 18,461 shares of the Company’s Series F Convertible Preferred Stock at a Warrant
Price of $6.50 per share. Terms defined in the Warrant are used herein as therein defined. As a result of the initial public offering of the shares of the Company’s common stock, par value $.01 per share (the “Common Stock”), the
number and/or class of securities issuable upon exercise or conversion of this Warrant has changed. 
  

			
	Pursuant to Article 2 of the Warrant, the Warrant is hereby amended as follows:
		
	Number of Shares:	  	“6153.67”
		
	Class of Stock:	  	“Common Stock”
		
	Warrant Price:	  	“$19.50 per share”

 This Amendment and the Warrant set forth in full all of the representations and agreements between the
parties with respect to the subject matter hereof and supersede all prior discussions, representations, agreements and understandings between the parties with respect to the subject hereof. Except as herein expressly amended, all of the terms and
provisions of the Warrant shall continue in full force and effect and the same are hereby ratified and confirmed. This Amendment is deemed attached to and made part of the Warrant instrument, which all together shall comprise the Warrant instrument.

  

											
	Company:	 	Holder:	 	
			
	Ceres, Inc.	 	SVB Financial Group	 	
						
	By:	 	 /s/ Paul Kuc
	 		 	By:	  	 /s/ Scott Newman
	 	
	Name: Paul Kuc	 		 	Title: Portfolio & Funding Manager	 	
	Title: Chief Financial Officer	 		 		  		 	

  

			
	Ceres, Inc.
		
	By:	 	 /s/ Richard Hamilton

	Name: Richard Hamilton
	Title: President & Chief Executive OfficerAmendment No. 1 to Warrant to Purchase Shares of Series F Preferred Stock

 Exhibit 4.3.2 
 AMENDMENT NO. 1 TO WARRANT TO PURCHASE STOCK 
 This Amendment No. 1
to Warrant to Purchase Stock (“Amendment”) is entered into as of June 20, 2012 between SVB Financial Group (“Holder”) and Ceres, Inc. (“Company”). 

Reference is made to that certain Warrant to Purchase Stock (the “Warrant”) issued by the Company in favor of Silicon Valley
Bank having the issue date of March 1, 2010, as assigned by Silicon Valley Bank to Holder. The Warrant originally granted to Holder the right to purchase 24,615 shares of the Company’s Series F Convertible Preferred Stock at a Warrant
Price of $6.50 per share. Terms defined in the Warrant are used herein as therein defined. As a result of the initial public offering of the shares of the Company’s common stock, par value $.01 per share (the “Common Stock”), the
number and/or class of securities issuable upon exercise or conversion of this Warrant has changed. 
  

			
	Pursuant to Article 2 of the Warrant, the Warrant is hereby amended as follows:
		
	Number of Shares:	  	“8205”
		
	Class of Stock:	  	“Common Stock”
		
	Warrant Price:	  	“$19.50 per share”

 This Amendment and the Warrant set forth in full all of the representations and agreements between the
parties with respect to the subject matter hereof and supersede all prior discussions, representations, agreements and understandings between the parties with respect to the subject hereof. Except as herein expressly amended, all of the terms and
provisions of the Warrant shall continue in full force and effect and the same are hereby ratified and confirmed. This Amendment is deemed attached to and made part of the Warrant instrument, which all together shall comprise the Warrant instrument.

  

											
	Company:	 	 	 	Holder:	 	 
				
	Ceres, Inc.	 	 	 	SVB Financial Group	 	 
						
	By:	 	 /s/ Paul Kuc
	 		 	By:	 	 /s/ Scott Newman
	 	
	Name: Paul Kuc	 		 	Title: Portfolio & Funding Manager	 	
	Title: Chief Financial Officer	 		 		 		 	

  

			
	Ceres, Inc.
		
	 By:
	 	 /s/ Richard Hamilton

	 Name: Richard Hamilton

	 Title: President & Chief Executive OfficerForm of Series F Original Warrant

 Exhibit 4.8 
 THIS WARRANT AND THE SECURITIES FOR WHICH IT MAY BE EXERCISED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR QUALIFIED OR REGISTERED UNDER STATE
SECURITIES OR BLUE SKY LAWS AND THE APPLICABLE RULES AND REGULATIONS THEREUNDER. THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION, AND NEITHER THESE SECURITIES NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE
SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT, APPLICABLE STATE SECURITIES OR BLUE SKY LAWS AND THE APPLICABLE RULES AND REGULATIONS THEREUNDER. THE ISSUER OF THIS
WARRANT MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER, IN ITS SOLE DISCRETION, TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS. THIS CERTIFICATE MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, PLEDGE OR OTHER TRANSFER OF ANY INTEREST IN ANY SECURITIES REPRESENTED BY THIS CERTIFICATE. 

THE SECURITIES FOR WHICH THIS WARRANT MAY BE EXERCISED WILL BE SUBJECT TO THE TERMS AND CONDITIONS OF AN AMENDED AND RESTATED RIGHT OF FIRST REFUSAL
AGREEMENT BY AND AMONG THE HOLDER, THE COMPANY AND CERTAIN HOLDERS OF CAPITAL STOCK OF THE COMPANY AND AN AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT AMONG THE HOLDER, THE COMPANY AND CERTAIN HOLDERS OF CAPITAL STOCK OF THE COMPANY. COPIES
OF THESE AGREEMENTS MAY BE OBTAINED UPON WRITTEN REQUEST OF THE SECRETARY OF THE COMPANY. 
 WARRANT TO PURCHASE SHARES OF COMMON
STOCK 
 of 
 CERES, INC. 
 This certifies that, for value received, [WARRANTHOLDER], a
                     corporation (the “Holder”), is entitled, subject to the terms set forth below, to purchase from Ceres, Inc., a
Delaware corporation (the “Company”) that certain number of shares of the Company’s common stock , par value $.01 per share (the “Common Stock”) as determined in Section 1 below, upon surrender hereof, at the principal
office of the Company referred to below, with the Notice of Exercise form attached hereto duly executed, and simultaneous payment therefor in lawful money of the United States or otherwise as hereinafter provided, at the Exercise Price set forth in
Section 3 below. The number of shares for which this Warrant shall be exercisable and the Exercise Price per share of Common Stock are subject to adjustment from time to time as provided in Section 10 below. The term “Warrant” as
used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. 

 1. Number of Shares. This Warrant shall be exercisable for an aggregate of
                     shares (the “Shares”) of Common Stock, subject to adjustment pursuant to Section 10 hereof. 

2. Term of Warrant. This Warrant shall be exercisable at any time prior to the 8th (eighth) anniversary of the date hereof. Nothing to the contrary
withstanding, this Warrant shall terminate upon and may no longer be exercised after the earliest to occur of: (i) the closing of a bona fide, firm commitment underwritten public offering pursuant to an effective registration statement under
the Securities Act of 1933, as amended, covering the offer and sale of Common Stock to the public on either the New York Stock Exchange or the NASDAQ National Market at a price per share greater than or equal to $6.50 per share (adjusted to reflect
stock dividends, stock splits or recapitalizations), resulting in aggregate gross proceeds to the Company and any selling security holders of $40 million or more (“Qualified Initial Public Offering”) or (ii) the occurrence of the
merger or consolidation of the Company into, or the sale of all or substantially all of the Company’s assets to, another corporation, unless the stockholders of the Company immediately prior to such merger, consolidation or sale shall own ,
immediately after such merger, consolidation or sale, at least a majority of the capital stock or voting power of the surviving or acquiring corporation (or a parent entity thereof). The Company shall notify the Holder in writing of the transactions
described in clauses (i) and (ii) above no later than thirty (30) days prior to, but not earlier than sixty (60) days prior to, the closing thereof. 
 3. Exercise Price. The exercise price shall be $6.50 per share (the “Exercise Price”). 
 4. Exercise of Warrant. 
 (a) The purchase rights for the
Shares represented by this Warrant are exercisable by the Holder in whole or in part, such number of Shares and the Exercise Price being subject to adjustment as provided in Section 10 below, at any time, or from time to time, during the term
hereof as described in Section 2 above, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly completed and executed on behalf of the Holder, at the office of the Company (or such other office or agency of the Company
as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company), upon payment in cash, by cashier’s check or by wire transfer in immediately available funds, of the purchase price of
the Shares to be purchased. 
 (b) This Warrant shall be deemed to have been exercised immediately prior to the
close of business on the date of its surrender for exercise as provided above, and the person entitled to receive the Shares issuable upon such exercise shall be treated for all purposes as the holder of record of such Shares as of the close of
business on such date. As promptly as practicable on or after such date and in any event within ten (10) business days thereafter, the Company at its expense shall issue and deliver to the person or persons entitled to receive the same a
certificate or certificates for the number of Shares issuable upon such exercise. In the event that this Warrant is exercised in part, the Company at its expense will execute and deliver a new Warrant of like tenor exercisable for the number of
Shares for which this Warrant may then be exercised. All other terms 

  
 2 

 
and conditions of such amended Warrant shall be identical to those contained herein. If the Holder shall have received a notice from the Company as contemplated by Section 2 hereof, the
Holder may exercise this Warrant conditioned upon the closing of the offering, merger, consolidation or sale that is referenced in such notice. 
 (c) Net Issue Exercise. Notwithstanding any provisions herein to the contrary, if the fair market value of one share of Common Stock is greater than the Exercise Price (at the date of calculation
as set forth below), in lieu of exercising this Warrant for cash, the Holder may elect to receive shares equal to the value (as determined below) of this Warrant (or the portion thereof being canceled) by the surrender of this Warrant at the office
of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company) together with the Notice of Exercise annexed hereto duly
completed and executed on behalf of the Holder and notice of such election in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula: 

 

							
	X  =	  	  Y (A-B)	  	
		  	A	  	
				
	Where	  	  X	  	=	  	the number of shares of Common Stock to be issued to the Holder
				
		  	  Y	  	=	  	the number of shares of Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date
of such calculation)
				
		  	  A	  	=	  	the fair market value of one share of the Common Stock (at the date of such calculation)
				
		  	  B	  	=	  	Exercise Price (as adjusted to the date of such calculation)

 For purposes of the above calculation, the fair market value of one share of Common Stock shall be
determined as follows: 
 (i) in the event the Warrant is exercised in connection with a Qualified Initial Public Offering, the
per share offering price to the public of the Company’s Common Stock in such initial public offering. 
 (ii) in the event
that the Common Stock is listed or admitted to trading on the NASDAQ National Market or any other national securities exchange, the average of the last reported sales price on such exchange for the ten (10) consecutive trading days prior to the
date of determination of such fair market value; 
 (iii) in the event such security is no longer listed or admitted to trading
on any national securities exchange or traded on any national market system, the average of the reported closing bid and ask prices in the over-the-counter market on such date as shown by the NASD automated quotation system, or if such securities
are 

  
 3 

 
not then quoted on such system, as published by the National Quotation Bureau, Incorporated or any similar successor organization, and in either case as reported by any member firm of any
national securities exchange selected by the Company; or 
 (iv) in the event clauses (i), (ii) or (iii) are not
applicable, the fair market value as determined by the Company’s Board of Directors in good faith. 
 5. No Fractional
Shares or Scrip. No fractional Shares or scrip representing fractional Shares shall be issued upon the exercise of this Warrant. In lieu of any fractional Share to which the Holder would otherwise be entitled, the Company shall make a cash
payment equal to the Exercise Price multiplied by such fraction. 
 6. Replacement of Warrant. On receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an affidavit of loss of stock certificate and indemnity agreement reasonably
satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount.

 7. Rights of Stockholders. Subject to Section 10 of this Warrant, the Holder, in its capacity as such, shall not
be entitled to vote or receive dividends or be deemed the holder of the Shares or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer
upon the Holder, as such, any of the rights of a stockholder of the Company, such as any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, to give or withhold consent to any corporate
action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance or otherwise), to receive notice of meetings, or to receive dividends
or subscription rights or otherwise, until the Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have been issued, as provided herein. 

8. Transfer of Warrant. 
 (a) Warrant Register. The Company will maintain a register (the “Warrant Register”) containing the names and addresses of the Holder or Holders. Any Holder of this Warrant may change its
address as shown on the Warrant Register by written notice to the Company requesting such change. Any notice or written communication required or permitted to be given to the Holder may be delivered or given by mail to such Holder as shown on the
Warrant Register and at the address shown on the Warrant Register. Until this Warrant is transferred on the Warrant Register of the Company, the Company may treat the Holder as shown on the Warrant Register as the absolute owner of this Warrant for
all purposes, notwithstanding any notice to the contrary. 
 (b) Warrant Agent. The Company may, by
written notice to the Holder, appoint an agent for the purpose of maintaining the Warrant Register referred to in Section 8(a) above, issuing the Shares or other securities then issuable upon the exercise

  
 4 

 
of this Warrant, exchanging this Warrant, replacing this Warrant, or any or all of the foregoing. Thereafter, any such registration, issuance, exchange or replacement, as the case may be, shall
be made at the office of such agent. 
 (c) Transferability and Non-negotiability of Warrant. This Warrant
may not be transferred or assigned in whole or in part without the prior written consent of the Company. Any transfer of this Warrant must comply with the requirements of this Section 8, and any assignee or transferee of this Warrant shall be
required to accept this Warrant subject to all rights and obligations of the Holder set forth herein. In addition, this Warrant may not be transferred in whole or in part without compliance with all applicable Federal and state securities laws by
the transferor and the transferee (including the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, if such are requested by the Company). Notwithstanding anything to the contrary herein, this
Warrant is, and the securities for which it may be exercised will be, subject to the restrictions on transfer set out in the Fifth Amended and Restated Right of First Refusal and Co-Sale Agreement dated September 5, 2007, as amended (the
“Right of First Refusal and Co-Sale Agreement”), among the Company, the Investors (as defined therein) and the Founders (as defined therein), except as provided in Section 3.2 of such Right of First Refusal and Co-Sale Agreement.

 (d) Exchange of Warrant Upon a Transfer. On surrender of this Warrant for exchange, properly endorsed
on the Assignment Form and subject to the provisions of this Warrant with respect to compliance with all applicable Federal and state securities laws, and with the limitations on assignments and transfers and contained in this Section 8, the
Company at its expense shall issue to or on the order of the Holder a new warrant or warrants of like tenor, in the name of the Holder or as the Holder (on payment by the Holder of any applicable transfer taxes) may direct, for the number of Shares
issuable upon exercise thereof. 
 (e) Compliance with Securities Laws. 

(i) The Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant and the Shares to be issued upon
exercise hereof are being acquired solely for the Holder’s own account and not as a nominee for any other party, for investment, and that the Holder will not offer, sell, pledge, hypothecate or otherwise transfer or dispose of this Warrant or
any Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act or any state securities or blue sky laws. 

(ii) This Warrant and all Shares issued upon exercise hereof shall be stamped or imprinted with legends in substantially
the following forms (in addition to any legend required by state securities laws or any agreement to which the Holder is a party): 
 (A) “THIS WARRANT AND THE SECURITIES FOR WHICH IT MAY BE EXERCISED HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE 

  
 5 

 
“SECURITIES ACT”) OR QUALIFIED OR REGISTERED UNDER STATE SECURITIES OR BLUE SKY LAWS, AND THE APPLICABLE RULES AND REGULATIONS THEREUNDER. THESE SECURITIES HAVE BEEN ACQUIRED FOR
INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION, AND NEITHER THESE SECURITIES NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT IN COMPLIANCE WITH THE
SECURITIES ACT, APPLICABLE STATE SECURITIES OR BLUE SKY LAWS AND THE APPLICABLE RULES AND REGULATIONS THEREUNDER. THE ISSUER OF THIS WARRANT MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER, IN ITS SOLE
DISCRETION, TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS CERTIFICATE MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO
THE SALE, PLEDGE OR OTHER TRANSFER OF ANY INTEREST IN ANY SECURITIES REPRESENTED BY THIS CERTIFICATE.” 

(B) “THE SECURITIES FOR WHICH THIS WARRANT MAY BE EXERCISED ARE SUBJECT TO THE TERMS AND CONDITIONS OF AN AMENDED
AND RESTATED RIGHT OF FIRST REFUSAL AGREEMENT BY AND AMONG THE HOLDER, THE CORPORATION AND CERTAIN HOLDERS OF CAPITAL STOCK OF THE COMPANY AND AN AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT AMONG THE HOLDER, THE COMPANY AND CERTAIN HOLDERS
OF CAPITAL STOCK OF THE COMPANY. COPIES OF THESE AGREEMENTS MAY BE OBTAINED UPON WRITTEN REQUEST OF THE SECRETARY OF THE COMPANY.” 
 9. Reservation of Stock. The Company covenants that during the term this Warrant is exercisable, the Company will reserve from its authorized and unissued Shares a sufficient number of shares to
provide for the issuance of the Shares upon the exercise of this Warrant and, from time to time, will take all steps necessary to amend its Certificate of Incorporation (the “Charter”) to provide sufficient reserves of Shares issuable upon
exercise of the Warrant. The Company further covenants that all Shares that may be issued upon the exercise of this Warrant, upon exercise of the rights represented by this Warrant and payment of the Exercise Price all as set forth herein, will be
duly authorized, validly issued and fully paid and non-assessable. The Company agrees that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and
issue the necessary certificates for the Shares upon the exercise of this Warrant. 

  
 6 

 10. Adjustments. The Exercise Price and the number of Shares purchasable hereunder
are subject to adjustment from time to time as follows: 
 10.1 Merger, Sale of Assets, Etc. 

(a) If at any time, while this Warrant, or any portion thereof, is outstanding and unexpired there shall be (i) a
reorganization (other than a combination, reclassification, exchange or subdivision of shares otherwise provided for herein), (ii) a merger or consolidation of the Company with or into another corporation in which the Company is not the
surviving entity, or a reverse triangular merger in which the Company is the surviving entity but the shares of the Company’s capital stock outstanding immediately prior to the merger are converted by virtue of the merger into other property,
whether in the form of securities, cash or otherwise, then, as a part of such reorganization, merger or consolidation, if any portion of the Warrant remains unexercised prior to such reorganization, merger or consolidation, lawful provision shall be
made so that the holder of this Warrant shall thereafter be entitled to receive upon exercise of this Warrant, during the periods specified herein and upon payment of the Exercise Price then in effect, the number of shares of stock or other
securities or property of the successor corporation resulting from such reorganization, merger or consolidation, which a holder of the Shares deliverable upon exercise of this Warrant would have been entitled to receive in such reorganization,
consolidation or merger if this Warrant had been exercised immediately before such reorganization, merger or consolidation, all subject to further adjustment as provided in this Section 10. The foregoing provisions of this Section 10.1
shall similarly apply to successive reorganizations, consolidations or mergers, and to the stock or securities of any other corporation which are at the time receivable upon the exercise of this Warrant. In all events, appropriate adjustment (as
determined in good faith by the Company’s Board of Directors) shall be made in the application of the provisions of this Warrant with respect to the rights and interests of the Holder after the transaction, to the end that the provisions of
this Warrant shall be applicable after that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this Warrant. 

(b) Notices of Record Date. In the event that the Company shall propose at any time to merge with or into any other
corporation, or sell, lease or convey all or substantially all its property or business, or to liquidate, dissolve or wind up, then the Company shall send to the holder of this Warrant at least ten (10) days’ prior written notice of the
date on which a record shall be taken for determining rights to vote in respect of such event. 
 10.2 Reclassification,
etc. If the Company at any time while this Warrant, or any portion thereof, remains outstanding and unexpired shall, by reclassification of securities or otherwise, change any of the securities as to which purchase rights under this Warrant
exist into the same or a different number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with
respect to the securities which were subject to the purchase rights under this Warrant immediately prior to such reclassification or other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as
provided in this Section 10. 

  
 7 

 10.3 Adjustments for Dividends in Stock or Other Securities or Property. If while
this Warrant, or any portion hereof, remains outstanding and unexpired the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or, on or after the record date fixed for the determination of
eligible stockholders, shall have become entitled to receive, without payment therefor, other or additional stock or other securities or property (including cash) of the Company by way of dividend, then and in each case, this Warrant shall represent
the right to acquire, in addition to the number of Shares of the security receivable upon exercise of this Warrant, and without payment of any additional consideration therefor, the amount of such other or additional stock or other securities or
property (including cash) of the Company which such holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period
from the date hereof to and including the date of such exercise, retained such shares and/or all other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions
of this Section 10. 
 10.4 Adjustment for Issuance of Additional Stock. If while this Warrant, or any portion
hereof, remains outstanding and unexpired the Company shall issue any capital stock or other securities that results in a decrease in the Conversion Price (as such term is defined in the Company’s Amended and Restated Certificate of
Incorporation) of the Company’s Series F Preferred Stock, then concurrent with such reduction of such Conversion Price, the Exercise Price shall be reduced to the amount of such Conversion Price. 

10.5 No Impairment. The Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Section 10 and in the taking of all such action as may be necessary or appropriate in
order to protect the rights of the holders of this Warrant against impairment. 
 11. Miscellaneous. 

11.1 Governing Law. This Warrant shall be governed by and construed under the laws of the State of Delaware as applied to
agreements among Delaware residents entered into and to be performed entirely within Delaware. 
 11.2 Entire Agreement.
This Warrant, the exhibits and schedules hereto, and the documents referred to herein, constitute the entire agreement and understanding of the parties hereto with respect to the subject matter hereof, and supersede all prior agreements and
understandings, whether oral or written, between the parties hereto with respect to the subject matter hereof. 
 11.3
Binding Effect. This Warrant and the various rights and obligations arising hereunder shall inure to the benefit of and be binding upon the Company and its successors and assigns, and Holder and its permitted successors and assigns.

  
 8 

 11.4 Waiver; Consent. Any term of this Warrant may be amended with the written
consent of the Company and the Holder(s). No waivers of or exceptions to any term, condition or provision of this Warrant, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term,
condition or provision. 
 11.5 Severability. If one or more provisions of this Warrant are held to be unenforceable
under applicable law, such provision shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and the balance shall be enforceable in accordance with its terms. 

[Remainder of Page Intentionally Left Blank] 

  
 9 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officers
thereunto duly authorized on September 5, 2007 
  

					
	CERES, INC.
		
	By:	 	  

		 	Name:	 	Richard Hamilton
		 	Title:	 	President and Chief Executive Officer
	
	[HOLDER]
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

 NOTICE OF EXERCISE 
 To: Ceres, Inc. 
 (1) The undersigned hereby elects to purchase
             shares of Common Stock, par value $.01 per share, of Ceres, Inc. (the “Shares”), pursuant to the terms of the attached Warrant. 

(2) The undersigned tenders herewith payment of the purchase price for such Shares in full: 

 

			
	 ̈	  	in cash
		
	 ̈	  	elects to receive a number of shares upon exercise calculated in accordance with Section 4(c) of the Warrant, if such section is applicable at the date of
exercise.

 (3) In exercising this Warrant, the undersigned hereby confirms and acknowledges that (i) the Shares
are being acquired solely for the account of the undersigned and not as a nominee for any other party, for investment, and that the undersigned will not offer, sell, pledge, hypothecate or otherwise transfer or dispose of any such Shares except
under circumstances that will not result in a violation of the Securities Act of 1933, as amended (the “Securities Act”), or any state securities or blue sky laws, and (ii) the undersigned is an “accredited investor” (as
defined in Rule 501(a) of Regulation D under the Securities Act. 
 (4) Please issue a certificate or certificates
representing said Shares in the name of the undersigned or in such other name as is specified below: 
  

	
	  

	[Name]
	
	  

	[Name]

 (5) Please issue a new Warrant for the unexercised portion of the attached Warrant in the name of
the undersigned or in such other name as is specified below: 
  

					
		 		 	  

		 		 	[Name]
			
	Date:                    , 20    	 		 	  

		 		 	[Signature]

 FORM OF ASSIGNMENT 

(To be executed by the registered holder hereof) 
 FOR VALUE RECEIVED, the undersigned registered owner of this Warrant hereby sells, assigns and transfers unto the assignee named below all the rights of the undersigned under this Warrant with respect to
the number of shares of Common Stock, par value $.01 per share, of Ceres, Inc. covered thereby set forth below: 
  

					
	 Name of Assignee
	  	 Address and Jurisdiction

of Organization
	  	 Number of Shares

of Common Stock

			
	  
	  	  
	  	  

		
		  	  

		
	Dated:
                            	  	Signature of Registered Holder
		
		  	  

		
		  	Name of Registered Holder
		  	(Please Print)
		
	Witness:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]